Decoding Longevity
Turning Biology of Aging into Medicines: A Conversation with James Peyer, Ph.D.
39:00
What if the future of medicine is preventing aging-related disease before it begins?
In this episode of Decoding Longevity, Raghav Sehgal and Macsue Jacques speak with James Peyer, CEO of Cambrian Biopharma, about turning aging biology into real therapeutics.
We explore exercise-mimetic drugs, metabolism reset therapies, mTOR inhibition, and the path to the first approved gerotherapeutics.